Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTT-705 with Simvastatin in Patients with Low HDL
NCT00688558Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Feb 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dyslipidemia comparing JTT-705 + Simvastatin with Placebo + Simvastatin (2 arms). Primary endpoints: Percent change from baseline in HDL-C at 4 weeks and Inhibition of CETP activity at 4 weeks. Started Feb 2004; status: completed.
02
Drugs
dalcetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00688558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688558.